Econ Market Research
Econ Market Research Report Cover

Neuromarketing Market

Neuromarketing Market Size, Share, Trends, Growth, and Industry Analysis, By Technology, By Offering, By Application, By End User, Regional Analysis and Forecast Period 2026-2035.

Last Updated:
Sep 22, 2026
Base year:
2025
Historical Data:
2022 - 2024
Region:
Global
Pages:
150+
Report Format:
PDF + Excel
Report ID:
EMR002434

Forecast Period

2026 - 2035

CAGR

6.30%

2026 Market Size

US$ 3.91 Billion

2035 Market Size

US$ 6.78 Billion

Neuromarketing Market Overview

As per Econ Market Research analysis, the Global Neuromarketing Market valuation stood at US$ 3.91 Billion in 2026 and is expected to reach US$ 6.78 Billion by 2035, growing at a steady CAGR of 6.30% from 2026 to 2035. 2025 serves as the base year.

The neuromarketing market combines neuroscience, behavioral science, biometrics, artificial intelligence, and consumer research to measure responses that conventional questionnaires may not capture. Commercial research programs increasingly combine electroencephalography, eye tracking, facial-expression analysis, electrodermal activity, heart-rate measurement, and implicit-response testing. EEG represented 40.28% of the technology segment in 2025, reflecting its ability to capture millisecond-level neural activity while remaining practical for advertising, packaging, digital-interface, and product-testing studies. The Neuromarketing Market is consequently shifting from isolated neuroscience experiments toward multimodal research environments that synchronize gaze, brain activity, physiological arousal, facial behavior, and stimulus events in a single analytical workflow.

Neuromarketing adoption in the United States is supported by a large advertising industry, digital-commerce ecosystem, consumer-products sector, technology base, and network of behavioral-science laboratories. U.S.-based enterprises use neuroscience-supported research for creative testing, online experience evaluation, packaging decisions, brand measurement, audience engagement, and product design. California's evolving treatment of neural and biometric information has increased attention to consent, data minimization, security, and participant governance within research programs. North America accounted for 41.20% of the global market in 2025, and the United States represents the region's principal concentration of commercial users, platform developers, research agencies, and technology companies.

Neuromarketing Market size and forecast chart showing growth from US$ 3.91 Billion in 2026 to US$ 6.78 Billion by 2035 at a CAGR of 6.30%.
Neuromarketing Market size forecast, 2026-2035

Europe combines an established behavioral-research ecosystem with stricter regulatory controls governing personal, biometric, and AI-derived information. Research providers operating across Denmark, Sweden, Switzerland, Belgium, Italy, Spain, Germany, France, and the United Kingdom supply eye-tracking systems, multimodal software, EEG technology, emotion analytics, and research services. The EU Artificial Intelligence Act restricts specified emotion-recognition uses in workplaces and educational institutions, which increases the importance of lawful purpose, transparency, participant consent, human oversight, and clearly documented research protocols. From August 2026, EU transparency obligations also apply to certain deployments involving emotion recognition or biometric categorization, creating a stronger compliance layer for European neuromarketing technology providers.

The Neuromarketing Market is moving toward software-driven, remote, scalable, and multimodal research rather than dependence on single laboratory instruments. Webcam-based gaze measurement, facial behavior analytics, remote participant testing, automated signal processing, and AI-assisted interpretation allow consumer studies to reach participants without requiring every session to take place in a specialized laboratory. Modern platforms can synchronize eye tracking, EEG, electrodermal activity, ECG, facial expressions, voice signals, respiration, and behavioral observations. This architecture reduces fragmented workflows and gives research teams a unified timeline for evaluating attention, emotional arousal, cognitive processing, and observable actions.

Software-only eye tracking represents another important shift. Browser-compatible and webcam-based solutions can extend attention measurement into websites, online advertising, digital-commerce platforms, remote UX testing, and application environments without dedicated laboratory hardware. Tobii introduced its software-based Nexus platform to enable eye-tracking integration through webcams, highlighting the industry's movement toward lower-friction deployment models. This approach expands neuromarketing beyond specialist laboratories and supports repeated testing during digital product development.

Multimodal integration is simultaneously becoming a competitive requirement. Research buyers increasingly seek platforms capable of combining several physiological and behavioral signals rather than treating gaze, neural activity, and emotion independently. iMotions, for example, supports integrated eye tracking, EEG, electrodermal activity, EMG, ECG, facial analysis, voice analysis, and fNIRS within its behavioral-research environment. The platform is used by over 1,500 organizations, demonstrating the commercial scale achievable through integrated research software rather than a single measurement modality.

Neuromarketing Market Dynamics

The Neuromarketing Market is shaped by the need to understand consumer responses beyond self-reported opinions. Traditional surveys remain important, but they cannot independently measure gaze behavior, physiological arousal, electrical brain activity, or automatic facial responses occurring during exposure to advertisements, packaging, websites, physical stores, and entertainment content. Behavioral platforms therefore combine explicit answers with objective measurements to create a richer research record. Commercial demand is strongest where marketing teams must choose between multiple creative assets, redesign interfaces, validate packaging, assess brand associations, or evaluate consumer reactions before large-scale deployment.

Artificial intelligence is further changing market dynamics by accelerating analysis of high-volume behavioral data. Automated facial analysis, gaze mapping, signal cleaning, event detection, predictive attention modeling, and visualization tools reduce the manual work previously required to interpret experimental sessions. Advertising and media testing represented 51.45% of application activity in 2025, indicating that campaign evaluation remains the largest commercial use case.

Drivers of Market Growth

DRIVER

Rising demand for objective consumer-attention and emotional-response measurement.

Brands face increasing pressure to evaluate advertising, packaging, interfaces, digital journeys, and products using behavioral evidence rather than stated preference alone. Neuromarketing systems provide measurable indicators of where consumers look, how long they remain attentive, when physiological activation changes, and how neural signals respond during exposure to stimuli. These capabilities are particularly useful when respondents cannot accurately explain subconscious or rapid reactions. Research platforms can connect these measurements with traditional surveys, enabling marketers to compare stated intention against observed behavior.

Digital commerce strengthens this driver because websites and applications can be tested repeatedly before deployment. Eye-tracking heat maps can reveal overlooked navigation elements, distracting page components, and visual hierarchy problems, while physiological measurements provide additional information about engagement or cognitive effort. Research cited by behavioral-platform providers indicates that stated intentions can explain only 28% of real-world behavior, reinforcing commercial interest in objective behavioral measurement.

Market Restraints

RESTRAINT

Privacy, ethical, regulatory, and biometric-data governance requirements.

Neuromarketing frequently involves information derived from faces, eyes, physiological signals, neural activity, voices, and behavioral responses. These datasets require stronger governance than ordinary campaign-performance metrics because they may relate directly to identifiable individuals or reveal characteristics that participants did not explicitly state. Organizations therefore need transparent consent procedures, data-retention policies, access restrictions, secure storage practices, anonymization controls, and defined research purposes before collecting or analyzing sensitive information.

European regulation provides a clear example of the compliance burden. The EU Artificial Intelligence Act prohibits specified emotion-recognition applications in workplace and educational contexts except defined medical or safety uses, while permitted biometric applications can remain subject to transparency and governance obligations. The regulation also acknowledges limitations in the reliability and generalizability of systems designed to infer emotions from biometric information. These requirements can slow procurement, increase legal review, restrict certain use cases, and favor suppliers capable of demonstrating defensible scientific and data-protection practices.

Market Opportunities

OPPORTUNITY

Expansion of remote and software-based behavioral research.

Remote neuromarketing creates opportunities to recruit geographically dispersed participants and test digital experiences in natural environments rather than requiring every respondent to visit a specialist facility. Webcam eye tracking, remote facial analysis, browser-based stimulus presentation, cloud platforms, and automated study administration can reduce logistical limitations associated with physical laboratories. These capabilities are especially relevant for advertising agencies, global brands, UX teams, e-commerce companies, media organizations, and academic researchers seeking larger or geographically varied participant pools.

The opportunity extends to continuous product-development workflows. Digital teams can integrate attention measurement into interface testing, compare alternative creative executions, validate online merchandising, and identify usability friction before public rollout. Browser integration also makes behavioral measurement accessible to developers who previously required specialized tracking hardware. Tobii's Nexus Web initiative extended software-based attention measurement into browser environments in 2025, illustrating how the technology is moving toward standard digital research infrastructure.

Market Challenges

CHALLENGES

Converting complex behavioral signals into reproducible business decisions.

Neuromarketing does not produce one universal indicator of consumer preference. EEG, eye tracking, electrodermal activity, facial behavior, heart rate, implicit testing, and fNIRS measure different biological or behavioral phenomena, and interpretation depends on experimental design, stimulus timing, calibration quality, participant characteristics, and statistical methodology. Poorly designed studies can therefore create attractive visualizations without generating reliable conclusions. Commercial adoption depends on converting multimodal datasets into findings that marketing, product, creative, and executive teams can understand.

Scientific validation presents another challenge because emotional expressions and physiological responses can vary across people, cultures, environments, and contexts. European regulatory guidance explicitly notes concerns regarding limited reliability, specificity, and generalizability in emotion-inference systems. Researchers increasingly address these limitations through multimodal validation, larger participant groups, controlled protocols, transparent algorithms, and comparison with behavioral outcomes.

Neuromarketing SWOT Analysis

Strengths

  • Neuromarketing captures behavioral and physiological responses that conventional questionnaires cannot directly measure.

  • Multimodal systems combine attention, neural activity, arousal, facial behavior, and explicit feedback within synchronized experiments.

  • The technology supports advertising, packaging, retail, UX, entertainment, pricing, and product-development decisions.

  • EEG held 40.28% of the technology segment in 2025, demonstrating established commercial acceptance of neuroscience-based measurement.

Weaknesses

  • Specialist study design and signal interpretation require trained researchers.

  • Results can be weakened by poor calibration, participant movement, environmental noise, or insufficient experimental controls.

  • Different measurement technologies assess different aspects of attention, arousal, or cognition rather than one universal consumer-response metric.

  • fMRI remains less practical for routine commercial testing because laboratory requirements restrict portability compared with lightweight EEG and eye-tracking systems.

Opportunities

  • Remote research can extend behavioral measurement to geographically distributed participant groups.

  • AI can automate signal processing, gaze analysis, emotion classification, visualization, and research workflows.

  • Wearable sensors can support studies in stores, events, transportation environments, and natural consumer settings.

  • Services controlled 45.63% of offering activity in 2025, leaving substantial scope for consulting, experimental design, interpretation, and managed research programs.

Threats

  • Expanding privacy regulation can restrict collection or interpretation of biometric and emotional information.

  • Weak scientific claims by low-quality providers can damage confidence in the wider industry.

  • Automated predictive-attention systems may substitute for selected physical research sessions.

  • EU rules specifically restrict defined emotion-recognition applications, increasing compliance exposure for suppliers operating across regulated use cases.

Neuromarketing Segmentation Analysis

The Neuromarketing Market can be segmented by technology, offering, application, and end user. Technology segmentation separates neural, gaze, physiological, facial, and optical measurement approaches. Offering segmentation differentiates physical devices from software environments and managed research services. Application segmentation identifies the business decision being tested, while end-user segmentation distinguishes organizations purchasing or operating neuromarketing capabilities. Retail and consumer brands represented 37.12% of end-user activity in 2025, reflecting extensive use of behavioral research for packaging, merchandising, advertising, product positioning, shopper analysis, and customer experience.

By Technology

Electroencephalography, functional magnetic resonance imaging, eye tracking, biometrics, facial coding and emotion AI, functional near-infrared spectroscopy, and other technologies form the core technical segmentation. EEG supports real-time measurement of electrical brain activity and is suited to advertising, media, product, and cognitive-response studies. Eye tracking identifies visual attention and fixation patterns, making it useful for packaging, retail shelves, websites, mobile applications, advertisements, and interfaces. Biometrics capture physiological signals, while facial coding evaluates observable expressions and fNIRS measures changes related to cerebral blood oxygenation.

EEG held 40.28% of the technology segment in 2025. Its leadership reflects established research protocols, high temporal resolution, improving portability, and increasing availability of wearable systems. fMRI remains important for high-resolution neuroimaging, while portable eye-tracking and fNIRS technologies support testing outside conventional laboratory environments.

By Offering

Hardware and devices include EEG headsets, eye trackers, physiological sensors, cameras, fNIRS systems, amplifiers, synchronization equipment, and laboratory accessories. Software and platforms manage experiment design, stimulus presentation, data synchronization, signal processing, visualization, analysis, participant administration, and reporting. Services include experimental design, participant recruitment, managed studies, data interpretation, strategic consulting, creative evaluation, and behavioral-research programs delivered for brands and agencies.

Services accounted for 45.63% of offering activity in 2025. This position reflects the specialist expertise required to select suitable research methods, design valid experiments, manage participants, interpret several biosignals, and convert technical results into commercially usable recommendations. Software platforms are gaining importance as organizations establish internal research capabilities, while hardware remains essential for studies requiring direct physiological or neurological measurement.

By Application

Advertising and media testing evaluates attention, engagement, creative effectiveness, scene performance, message delivery, and emotional response. Product and packaging design examines visual hierarchy, shelf visibility, form, labeling, and product interaction. User experience and digital analytics assess websites, applications, interfaces, and digital journeys. Retail and in-store analytics measure shelf attention and shopper behavior, while pricing research, political and social campaign testing, and specialized applications extend the use of behavioral science into additional decision environments.

Advertising and media testing held 51.45% of application activity in 2025. The segment benefits from the high cost of poorly performing creative material and the ability to test multiple executions before media deployment. Neuromarketing tools help identify where attention declines, which elements receive visual focus, and how participants respond during specific moments in an advertisement or digital experience.

By End User

Banking and financial services organizations apply behavioral research to digital journeys, communication testing, trust cues, and financial decision interfaces. Retail and consumer brands use neuromarketing for advertising, packaging, merchandising, store layout, product concepts, and shopper research. Market research agencies provide managed studies across client industries, while scientific institutions use behavioral technology for academic and experimental research. Healthcare, pharmaceuticals, media, entertainment, e-commerce, and technology organizations apply related methods to communication, UX, content, patient engagement, and digital product development.

Retail and consumer brands accounted for 37.12% of end-user activity in 2025. Their leadership reflects the direct connection between consumer attention and decisions involving packaging, shelf placement, advertising, digital commerce, and product positioning. Market research agencies remain important intermediaries because many brands continue to outsource specialist study design and analysis.

Regional Analysis

Regional performance reflects differences in advertising maturity, digital-commerce adoption, consumer-research infrastructure, technology availability, academic neuroscience capabilities, and privacy regulation. North America maintains the largest commercial concentration, while Europe has a strong technology and behavioral-science supplier base. Asia-Pacific is expanding its use of consumer analytics alongside digital retail and mobile commerce. Middle East and Africa represent developing neuromarketing environments supported by advertising modernization, retail investment, academic research, and increased use of digital customer-experience tools.

North America

  • North America remains the largest regional Neuromarketing Market because the region combines major advertisers, consumer brands, research agencies, technology companies, universities, digital-commerce platforms, and behavioral-science laboratories. Organizations use eye tracking, EEG, biometric measurement, facial analysis, implicit testing, and predictive-attention tools across advertising, online retail, packaging, entertainment, user experience, and product development.

  • The regional ecosystem also supports commercialization of portable neurotechnology and software-driven research. U.S.-based EMOTIV develops wearable EEG systems, Immersion Neuroscience operates in neuroscience-based audience measurement, and several enterprise technology companies integrate AI-driven customer analytics into larger platforms. Strong digital-advertising activity creates repeated demand for pre-launch creative testing and digital-experience optimization.

  • North America held 41.20% of global activity in 2025. This position is reinforced by corporate research budgets, established consumer-insights functions, access to technical talent, extensive e-commerce activity, and early adoption of emerging analytics tools. Privacy regulation is simultaneously increasing scrutiny of neural and biometric data, encouraging suppliers to incorporate consent, security, anonymization, governance, and clearly defined research purposes into commercial deployments.

Europe

  • Europe has a substantial concentration of neuromarketing technology suppliers and behavioral-research expertise. Denmark hosts Neurons and iMotions, Sweden hosts Tobii, Switzerland hosts NVISO, Belgium hosts Mindspeller, Italy hosts SR Labs, and Spain hosts Bitbrain. This vendor base supports EEG research, eye tracking, emotion analysis, multimodal behavioral platforms, predictive attention models, and physiological measurement.

  • European adoption is shaped strongly by privacy and artificial-intelligence governance. Organizations conducting facial, biometric, or emotion-oriented research require careful participant information, lawful processing practices, defined retention procedures, and controls governing downstream analysis. These requirements favor vendors that can demonstrate scientific validity and enterprise-grade governance.

  • Independent market estimates position Europe as the second major global cluster after North America, with the balance distributed across Asia-Pacific and other regions. The regulatory environment is particularly important because the EU AI Act restricts emotion recognition in workplace and educational settings while imposing transparency obligations on permitted deployments. This creates opportunities for privacy-preserving systems, on-device analysis, anonymized behavioral measurement, and clearly consented consumer-research applications.

Asia-Pacific

  • Asia-Pacific is developing as an important neuromarketing region due to rapid digital-commerce adoption, mobile-first consumer behavior, expanding retail ecosystems, streaming-media consumption, advertising technology, and increased investment in customer-experience analytics. Businesses in China, Japan, South Korea, India, Australia, and Southeast Asian economies increasingly evaluate interfaces, advertisements, products, stores, and digital campaigns using behavioral measurement.

  • The region also benefits from manufacturing capabilities in sensors and electronics, strong university research communities, and large digital consumer populations. Mobile commerce creates significant opportunities for webcam-based eye tracking and software-driven attention analytics because research can be incorporated into digital-product testing without full neuroscience laboratories.

  • Asia-Pacific remains behind North America in current global share, but research providers identify the region as one of the strongest areas for new adoption. Its expansion is supported by consumer brands seeking localized behavioral evidence across culturally diverse markets. Multimodal systems are particularly relevant because visual attention, explicit responses, and emotional expressions can differ by cultural context, making locally designed experiments essential for dependable interpretation.

Middle East & Africa

  • The Middle East and Africa Neuromarketing Market is smaller than the three major global regions but is developing through premium retail, tourism, financial services, telecommunications, media, advertising, and digital transformation. Gulf economies provide opportunities for behavioral research related to shopping malls, hospitality, aviation, luxury products, digital banking, entertainment, and major events. South Africa also contributes specialized research capabilities through companies such as Neural Sense.

  • Universities and research institutions are important entry points because EEG, eye tracking, behavioral science, psychology, and human-computer interaction programs create technical expertise that can later support commercial applications. Remote research tools also reduce dependence on large laboratory networks and allow studies to reach participants across dispersed locations.

  • Middle East and Africa represents a single-digit portion of global neuromarketing activity in current industry estimates. Commercial penetration depends on research awareness, availability of specialist skills, data-governance requirements, equipment access, and corporate willingness to integrate neuroscience-supported findings with existing consumer research. Digital advertising and customer-experience modernization provide a practical route for continued adoption.

Competitive Landscape

The Neuromarketing Market is fragmented across behavioral-research platforms, sensor manufacturers, neuroscience specialists, research agencies, AI providers, and eye-tracking companies. Competition increasingly centers on multimodal integration rather than individual hardware products. Platforms capable of synchronizing gaze, EEG, electrodermal activity, facial responses, heart signals, respiration, voice, and experimental events can reduce the need for researchers to operate separate analytical systems.

Technology vendors are also lowering deployment barriers through software-only products, wearable sensors, remote-data collection, and automated analysis. Eye-tracking providers compete on calibration speed, accuracy, sampling performance, integration options, webcam support, SDK availability, and compatibility with different operating environments. EEG suppliers compete on channel configuration, portability, setup requirements, signal quality, software integration, and suitability for field research.

Competitive differentiation is increasingly based on AI-supported analysis and workflow automation. Vendors are incorporating machine learning for signal processing, facial analysis, gaze interpretation, predictive attention, automated visualization, and scalable remote studies. Services retain 45.63% of offering activity, confirming that specialist expertise remains strategically important even as software becomes easier to operate.

List of Top Neuromarketing Companies

  • Nielsen (U.S.)

  • Neurons Inc. (Denmark)

  • Immersion Neuroscience Inc. (U.S.)

  • NVISO SA (Switzerland)

  • Cadwell Industries Inc. (U.S.)

  • Compumedics Limited (Australia)

  • Merchant Mechanics Inc. (U.S.)

  • Neural Sense (South Africa)

  • SR Labs SRL (Italy)

  • Mindspeller BV (Belgium)

  • Tobii AB (Sweden)

  • iMotions A/S (Denmark)

  • Bitbrain Technologies SL (Spain)

  • EMOTIV Inc. (U.S.)

  • Uniphore Technologies Inc. (U.S.)

Leading Companies by Market Share

  • Nielsen: Nielsen maintains a prominent position in consumer measurement and behavioral research, supported by its established relationships with advertisers, media organizations, and consumer brands. A dependable audited percentage specifically separating Nielsen's neuromarketing activities from its broader measurement operations is not publicly disclosed, so assigning a fabricated company-level market share would not provide a valid industry comparison.

  • iMotions A/S: iMotions is a major specialist in integrated human-behavior research software, combining eye tracking and multiple biosensor modalities within a common platform. The company reported that its platform was used by over 1,500 organizations when iMotions 11 was introduced, although an audited percentage of the total Neuromarketing Market is not publicly disclosed.

Investment in the Neuromarketing Market is increasingly directed toward software platforms, AI-driven interpretation, remote data collection, wearable sensing, and multimodal integration. These areas can expand research capacity without requiring an equivalent increase in laboratory infrastructure. Investors and corporate buyers are particularly interested in technologies that reduce setup complexity and shorten the distance between raw behavioral signals and actionable research findings.

Software-only attention measurement is attractive because it can be embedded into digital research workflows and deployed across larger participant populations. Webcam-based eye tracking reduces dependency on dedicated tracking equipment for selected applications, while remote facial and physiological analysis can extend behavioral studies into participants' natural environments. These deployment models create opportunities for subscription platforms and standardized enterprise research tools.

Wearable neuroscience represents another investment area. EEG headsets, EEG-enabled earphones, lightweight optical brain-imaging devices, mobile eye trackers, and integrated biosensors enable research outside controlled facilities. EMOTIV's MW20, introduced in 2025, illustrates how EEG sensing is moving into familiar consumer hardware formats rather than remaining confined to traditional headsets.

Product Innovation & Development

Product development is focused on portability, remote measurement, AI-assisted analysis, multimodal synchronization, browser integration, and simplified research workflows. Neuromarketing technology historically required specialist hardware and controlled testing environments, but suppliers increasingly design products that support field studies, remote participants, online interfaces, and rapid experimental iteration.

Eye-tracking innovation demonstrates this direction clearly. Software-based platforms can generate attention data through existing cameras, while dedicated trackers remain available when research requires higher sampling performance or controlled precision. Developers are also embedding gaze technology into smart glasses, mixed-reality devices, healthcare systems, computers, and commercial applications.

Behavioral-research platforms are expanding the number of synchronized data channels available within one experiment. iMotions supports combinations of eye tracking, EEG, electrodermal activity, EMG, ECG, fNIRS, facial analysis, voice measurement, and other behavioral inputs. Its iMotions 11 release added enhanced automation, machine-learning functionality, visualization improvements, and broader sensor support to a platform deployed across over 1,500 organizations.

Recent Developments (2023–2026)

  • In May 2026, iMotions introduced an Android-focused Affectiva Emotion SDK designed to perform privacy-oriented emotion analysis directly on compatible devices.

  • In February 2026, iMotions launched a motion-capture module that expanded its human-behavior platform with movement measurement that can be synchronized with other research signals.

  • In November 2025, iMotions released iMotions 11 with expanded automation, machine-learning tools, visualization capabilities, workflow enhancements, and additional sensor support for behavioral research.

  • In September 2025, Tobii extended its Nexus technology to browser-based applications through Tobii Nexus Web, enabling software-based attention measurement within web environments.

  • In January 2025, EMOTIV introduced MW20 EEG active-noise-cancelling earphones that combine audio hardware with embedded brain-sensing technology for cognitive and wellness applications.

  • In June 2024, Tobii launched Nexus as its first software-only eye-tracking integration platform, allowing compatible webcam-equipped devices and applications to generate attention data without a dedicated tracker.

Scope of the Neuromarketing Market Report

The Neuromarketing Market report covers the technologies, offerings, applications, end users, competitive environment, geographic structure, investment patterns, innovation activity, and regulatory factors influencing neuroscience-supported consumer research. Technology coverage includes electroencephalography, functional magnetic resonance imaging, eye tracking, biometrics, facial coding and emotion AI, functional near-infrared spectroscopy, and additional behavioral-measurement technologies. The analysis examines how different tools capture neural, visual, physiological, emotional, and behavioral responses during controlled and real-world research.

Offering coverage includes hardware and devices, software and platforms, and specialist services. Application analysis evaluates advertising and media testing, product and packaging design, UX and digital analytics, retail research, pricing studies, campaign testing, and other commercial uses. End-user coverage incorporates banking and financial services, retail and consumer brands, research agencies, scientific institutions, healthcare, pharmaceuticals, media, entertainment, e-commerce, technology companies, and additional industries.

Regional coverage evaluates North America, Europe, Asia-Pacific, Middle East and Africa while accounting for technology adoption, research infrastructure, digital-commerce activity, advertising maturity, privacy requirements, and vendor presence. Competitive assessment addresses established research companies, sensor manufacturers, software developers, AI providers, and specialist neuroscience firms. The report also evaluates emerging developments including remote research, multimodal analytics, wearable neuroscience, privacy-preserving emotion measurement, browser-based eye tracking, and AI-assisted behavioral analysis, with North America's 41.20% share serving as the principal regional benchmark for current market structure.

Neuromarketing Market Report Scope & Segmentation

AttributesDetails
Market Size (Current)Current market valuationUS$ 3.91 Billion in 2026
Market Size (Forecast)Projected market valuationUS$ 6.78 Billion in 2035
Growth RateCompound Annual Growth RateCAGR of 6.30% from 2026 to 2035
Forecast PeriodAnalysis timeline2026 – 2035
Base YearReference year for analysis2025
Historical Data AvailablePast market data availabilityYes
Regional ScopeGeographical coverageGlobal
Segments CoveredMarket segments analyzed

By Technology

  • Electroencephalography (EEG)

  • Functional Magnetic Resonance Imaging (fMRI)

  • Eye Tracking

  • Biometrics

  • Facial Coding / Emotion AI

  • Functional Near-Infrared Spectroscopy (fNIRS)

  • Other Technologies


By Offering

  • Hardware / Devices

  • Software / Platforms

  • Services


By Application

  • Advertising and Media Testing

  • Product and Packaging Design

  • User Experience and Digital Analytics

  • Retail and In-Store Analytics

  • Pricing Research

  • Political and Social Campaign Testing

  • Other Applications


By End User

  • Banking, Financial Services and Insurance

  • Retail and Consumer Brands

  • Market Research Agencies

  • Scientific Institutions

  • Healthcare and Pharmaceuticals

  • Media and Entertainment

  • E-Commerce and Technology

  • Other End Users

Key Market Players

Leading companies covered in this report

  • Nielsen (U.S.)
  • Neurons Inc. (Denmark)
  • Immersion Neuroscience Inc. (U.S.)
  • NVISO SA (Switzerland)
  • Cadwell Industries Inc. (U.S.)
  • Compumedics Limited (Australia)
  • Merchant Mechanics Inc. (U.S.)
  • Neural Sense (South Africa)
  • SR Labs SRL (Italy)
  • Mindspeller BV (Belgium)
  • Tobii AB (Sweden)
  • iMotions A/S (Denmark)
  • Bitbrain Technologies SL (Spain)
  • EMOTIV Inc. (U.S.)
  • and Uniphore Technologies Inc. (U.S.)

Frequently Asked Questions

Common questions about this report

The study period covers historical insights and forecast projections for the period 2026-2035.

About the Author

Market research expert with years of industry experience

Rahul Garje

Rahul Garje

RESEARCH ASSOCIATE

I’m Rahul Garje, a Research Associate at Econ Market Research, specializing in data collection, market analysis, and supporting industry reports with accurate insights and trends.

Related Reports

Explore more market insights from the same category

Our Clients

3M logo
Accenture logo
Apyx Medical logo
Atlas Copco logo
GE General Electric logo
IBM logo
Johnson and Johnson logo
LEK Consulting logo
Leschaco logo
Medtronic logo
TruGolf logo
Wieth Medical logo
3M logo
Accenture logo
Apyx Medical logo
Atlas Copco logo
GE General Electric logo
IBM logo
Johnson and Johnson logo
LEK Consulting logo
Leschaco logo
Medtronic logo
TruGolf logo
Wieth Medical logo